Solicitation of Nominations for Appointment to the Lead Exposure and Prevention Advisory Committee (LEPAC)
| Published date | 28 October 2020 |
| Citation | 85 FR 68328 |
| Record Number | 2020-23804 |
| Section | Notices |
| Court | Centers For Disease Control And Prevention |
Federal Register, Volume 85 Issue 209 (Wednesday, October 28, 2020)
[Federal Register Volume 85, Number 209 (Wednesday, October 28, 2020)]
[Notices]
[Pages 68328-68329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23804]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Lead Exposure
and Prevention Advisory Committee (LEPAC)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
soliciting nominations for membership on the LEPAC. The LEPAC consists
of 15 Federal and non-Federal experts in fields associated with lead
screening, the prevention of lead exposure, and services for
individuals and communities affected by lead exposure. Nominations are
being sought for individuals who have expertise and qualifications
necessary to contribute to the accomplishment of the committee's
objectives. Nominees will be selected based on expertise in the fields
of epidemiology, toxicology, mental health, pediatrics, early childhood
education, special education, diet and nutrition, and environmental
health. Members may be invited to serve for three-year terms. Selection
of members is based on candidates' qualifications to contribute to the
accomplishment of LEPAC objectives.
DATES: Nominations for membership on the LEPAC must be received no
later than December 15, 2021. Packages received after this time will
not be considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to [email protected].
FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated
Federal Officer, National Center for Environmental Health, CDC, 4770
Buford Highway, Atlanta, GA 30341, 770-488-3300, [email protected].
SUPPLEMENTARY INFORMATION: The members of this committee are selected
by the Secretary of the U.S. Department of Health and Human Services
(HHS). The committee advises the Secretary, HHS and the Director,
Centers for Disease Control and Prevention/Administrator, Agency for
Toxic Substances and Disease Registry on a range of activities to
include: (1) Review of Federal programs and services available to
individuals and communities exposed to lead; (2) review of the current
research on lead exposure to identify additional research needs; (3)
review of and identification of best practices, or the need for best
practices regarding lead screening and the prevention of lead exposure;
(4) identification of effective services, including services relating
to healthcare, education, and nutrition for individuals and communities
affected by lead exposure and lead poisoning, including in consultation
with, as appropriate, the lead exposure registry as established in
Public Law 114-322 Section 2203(b) (42 U.S.C. 300j-27); and (5)
undertaking of any other review or activities that the Secretary
determines to be appropriate.
[[Page 68329]]
Annually as determined necessary by the Secretary or as required by
Congress, the committee shall submit a report to include: (1) An
evaluation of the effectiveness of the Federal programs and services
available to individuals and communities exposed to lead; (2) an
evaluation of additional lead exposure research needs; (3) an
assessment of any effective screening methods or best practices used or
developed to prevent or screen for lead exposure; (4) input and
recommendations for improved access to effective services relating to
health care, education, or nutrition for individuals and communities
impacted by lead exposure; and (5) any other recommendations for
communities affected by lead exposure, as appropriate.
At least half of the committee will consist of Federal
representatives from a range of agencies that may include the
Department of Housing and Urban Development; the Environmental
Protection Agency; the Consumer Product Safety Commission; the Centers
for Medicare and Medicaid Services; the Health Resources and Services
Administration; the Food and Drug Administration; the U.S. Department
of Agriculture; the Occupational Safety and Health Administration; the
National Institute of Environmental Health Sciences; the U.S.
Geological Survey; and such additional federal, state, tribal, and
local public and private officials as the Secretary deems necessary for
the committee to carry out its function. The rest of the committee will
consist of non-Federal members. Only non-Federal members are being
solicited with this announcement.
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning and annually
during their terms. CDC reviews potential candidates for LEPAC
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment as soon as the HHS selection process is
completed. Note that the need for different expertise varies from year
to year and a candidate who is not selected in one year may be
reconsidered in a subsequent year. Nominees must be U.S. citizens, and
cannot be full-time employees of the U.S. Government.
Candidates should submit the following items:
Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.)
Nominations may be submitted by the candidate him- or herself or by
the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-23804 Filed 10-27-20; 8:45 am]
BILLING CODE 4163-18-P
